Table 2.

Clinical and laboratory data of renal patients with and without previous CV events from the baseline cohorta

CV Events(n = 28)No CV Events(n = 199)
Gender (male/female [%])24/4 (86/14)130/69b (65/35)
Age (yr)53.7 ± 6.5 44.5 ± 12.8c
Body mass index (kg/m2)25.8 ± 4.0 25.1 ± 3.8 
Current smoker (n)5 (18%)51 (26%)
Past smoker (n)10 (36%)47 (24%)
Serum creatinine (mg/dl)1.76 (1.40 to 2.59)1.60 (1.20 to 2.36)
GFR (ml/min per 1.73 m2)53 (33 to 78)64 (39 to 98)
Proteinuria (g/24 h per 1.73 m2)0.58 (0.09 to 1.72)0.56 (0.18 to 1.37)
High-sensitivity C-reactive protein (mg/L)1.90 (0.90 to 4.70)1.40 (0.60 to 3.90)
Intact parathyroid hormone (pmol/L)9.2 (4.7 to 18.0)5.7 (3.5 to 13.0)
Use of antihypertensive drugs (n)27 (96%)152 (76%)b
Systolic BP (mmHg)138 ± 21137 ± 21
Diastolic BP (mmHg)86 ± 1587 ± 14
Pulse pressure (mmHg)52 ± 1651 ± 15
Insulin (mU/L)17.4 ± 18.913.4 ± 7.5b
Glucose (mg/dl)100 ± 2098 ± 16
HOMA-IR5.12 ± 7.823.38 ± 2.49b
Adiponectin (μg/ml)4.1 ± 1.86.4 ± 4.4c
Total cholesterol (mg/dl)216 ± 48214 ± 45
LDL cholesterol (mg/dl)134 ± 49137 ± 39
Triglycerides (mg/dl)171 (114 to 332)139 (98 to 213)c
  • a CV, cardiovascular.

  • b P < 0.05, patients with and without previous CV events.

  • c P < 0.01, patients with and without previous CV events.